Regulation of apoptosis by Bcl‐2 family proteins
暂无分享,去创建一个
[1] S. Korsmeyer,et al. Caspase Cleaved BID Targets Mitochondria and Is Required for Cytochrome c Release, while BCL-XL Prevents This Release but Not Tumor Necrosis Factor-R1/Fas Death* , 1999, The Journal of Biological Chemistry.
[2] Junying Yuan,et al. Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis , 1998, Cell.
[3] S. Korsmeyer,et al. Solution Structure of the Proapoptotic Molecule BID A Structural Basis for Apoptotic Agonists and Antagonists , 1999, Cell.
[4] A. Zeiher,et al. Posttranslational Modification of Bcl-2 Facilitates Its Proteasome-Dependent Degradation: Molecular Characterization of the Involved Signaling Pathway , 2000, Molecular and Cellular Biology.
[5] S. Korsmeyer,et al. Cell Death in Development , 1999, Cell.
[6] D. Green,et al. Granzyme B Short-Circuits the Need for Caspase 8 Activity during Granule-Mediated Cytotoxic T-Lymphocyte Killing by Directly Cleaving Bid , 2000, Molecular and Cellular Biology.
[7] S. Korsmeyer,et al. BCL-2 family members and the mitochondria in apoptosis. , 1999, Genes & development.
[8] S. Korsmeyer,et al. Regulated Targeting of BAX to Mitochondria , 1998, The Journal of cell biology.
[9] E. Cheng,et al. Conversion of Bcl-2 to a Bax-like death effector by caspases. , 1997, Science.
[10] S. Fesik,et al. Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-XL , 1997, Molecular and cellular biology.
[11] N. Inohara,et al. harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival‐promoting proteins Bcl‐2 and Bcl‐XL , 1997, The EMBO journal.
[12] S. Korsmeyer,et al. Targeting of Bcl-2 to the mitochondrial outer membrane by a COOH-terminal signal anchor sequence. , 1993, The Journal of biological chemistry.
[13] J. Hansson,et al. Calpain-Mediated Bid Cleavage and Calpain-Independent Bak Modulation: Two Separate Pathways in Cisplatin-Induced Apoptosis , 2002, Molecular and Cellular Biology.
[14] Changlian Zhu,et al. Synergistic Activation of Caspase-3 by m-Calpain after Neonatal Hypoxia-Ischemia , 2001, The Journal of Biological Chemistry.
[15] S. Korsmeyer,et al. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis , 1998, The EMBO journal.
[16] A. Valette,et al. Bcl-2 phosphorylation and proteasome-dependent degradation induced by paclitaxel treatment: consequences on sensitivity of isolated mitochondria to Bid. , 2002, Experimental cell research.
[17] Y. Tsujimoto,et al. Involvement of the bcl-2 gene in human follicular lymphoma. , 1985, Science.
[18] W. May,et al. Bcl-2 Phosphorylation Required for Anti-apoptosis Function* , 1997, The Journal of Biological Chemistry.
[19] C. Milliman,et al. BID: a novel BH3 domain-only death agonist. , 1996, Genes & development.
[20] Elizabeth Yang,et al. Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL , 1996, Cell.
[21] B. Brüne,et al. ENDOTOXIC SHOCK LEADS TO APOPTOSIS IN VIVO AND REDUCES Bcl‐2 , 1996, Shock.
[22] Y. Lazebnik,et al. Caspases: enemies within. , 1998, Science.
[23] A. Strasser,et al. The Bcl-2 protein family. , 1999, Results and problems in cell differentiation.
[24] J. Krieglstein,et al. Serine/threonine protein phosphatases in apoptosis. , 2002, Current opinion in pharmacology.
[25] R. Meadows,et al. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death , 1996, Nature.
[26] R. Meadows,et al. Structure of Bcl-xL-Bak Peptide Complex: Recognition Between Regulators of Apoptosis , 1997, Science.
[27] S. Cory,et al. The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.
[28] Junying Yuan,et al. Solution Structure of BID, an Intracellular Amplifier of Apoptotic Signaling , 1999, Cell.
[29] Susan S. Taylor,et al. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. , 1999, Molecular cell.
[30] A. Strasser,et al. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. , 1999, Molecular cell.
[31] F. Lang,et al. Physiology of apoptosis. , 2000, American journal of physiology. Renal physiology.
[32] B. Corfe,et al. Cell Damage-induced Conformational Changes of the Pro-Apoptotic Protein Bak In Vivo Precede the Onset of Apoptosis , 1999, The Journal of cell biology.
[33] A. Rebollo,et al. Segregation of Bad from Lipid Rafts Is Implicated in the Induction of Apoptosis1 , 2002, The Journal of Immunology.
[34] Y. Hsu,et al. Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[35] C. Borner,et al. Alphaviruses induce apoptosis in Bcl‐2‐overexpressing cells: evidence for a caspase‐mediated, proteolytic inactivation of Bcl‐2 , 1998, The EMBO journal.
[36] L. Peso,et al. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. , 1997, Science.
[37] Weiya Ma,et al. Activation of JNK1, RSK2, and MSK1 Is Involved in Serine 112 Phosphorylation of Bad by Ultraviolet B Radiation* , 2002, The Journal of Biological Chemistry.
[38] J. Martinou,et al. The Bcl-2 protein family. , 2000, Experimental cell research.
[39] John Calvin Reed,et al. Upregulation of bax protein levels in neurons following cerebral ischemia , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[40] H. Lodish. Molecular Cell Biology , 1986 .
[41] S. R. Datta,et al. Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery , 1997, Cell.
[42] R. Gascoyne,et al. Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes. , 1994, The American journal of pathology.
[43] S. Korsmeyer,et al. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.
[44] John Calvin Reed,et al. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene , 1995, Cell.
[45] D. Thorley-Lawson,et al. A novel form of Epstein-Barr virus latency in normal B cells in vivo , 1995, Cell.
[46] S. Korsmeyer,et al. Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c , 2000, Cell Death and Differentiation.
[47] D. Chao,et al. BCL-2 family: regulators of cell death. , 1998, Annual review of immunology.
[48] Yi-Te Hsu,et al. Movement of Bax from the Cytosol to Mitochondria during Apoptosis , 1997, The Journal of cell biology.
[49] John Calvin Reed,et al. Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[50] Jean-Claude Martinou,et al. Bid-induced Conformational Change of Bax Is Responsible for Mitochondrial Cytochrome c Release during Apoptosis , 1999, The Journal of cell biology.
[51] A. Strasser,et al. Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins , 2002, Cell Death and Differentiation.
[52] E. Ruoslahti,et al. A Signaling Pathway from the α5β1 and αvβ3 Integrins That Elevatesbcl-2 Transcription* , 2001, The Journal of Biological Chemistry.
[53] John Calvin Reed,et al. Regulation of cell death protease caspase-9 by phosphorylation. , 1998, Science.
[54] A. Wyllie,et al. Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.
[55] John Calvin Reed,et al. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. , 1993, Cancer research.
[56] D. Andrews,et al. Bcl‐2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types. , 1996, The EMBO journal.
[57] C. Thompson,et al. Apoptosis in the pathogenesis and treatment of disease , 1995, Science.
[58] S. Izumo,et al. Apoptosis: basic mechanisms and implications for cardiovascular disease. , 1998, Circulation research.
[59] D G Kirsch,et al. Modulation of cell death by Bcl-XL through caspase interaction. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[60] R. Schreiber,et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death , 1990, Nature.
[61] G. Mulder,et al. Distinct Intracellular Signaling in Tumor Necrosis Factor-related Apoptosis-inducing Ligand- and CD95 Ligand-mediated Apoptosis* , 2002, The Journal of Biological Chemistry.
[62] W. Zong,et al. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. , 2001, Genes & development.
[63] S. Korsmeyer,et al. BH3 Domain of BAD Is Required for Heterodimerization with BCL-XL and Pro-apoptotic Activity* , 1997, The Journal of Biological Chemistry.
[64] S. Srinivasula,et al. Caspase Cleavage Enhances the Apoptosis-Inducing Effects of BAD , 2001, Molecular and Cellular Biology.
[65] Z. Oltvai,et al. Interleukin-3 Induces the Phosphorylation of a Distinct Fraction of Bcl-2* , 1999, The Journal of Biological Chemistry.